Source:http://linkedlifedata.com/resource/pubmed/id/13876252
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1962-12-1
|
pubmed:keyword | |
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
OM
|
pubmed:status |
OLDMEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0026-4784
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
475-8
|
pubmed:year |
1962
|
pubmed:articleTitle |
[Considerations on the use of a new orally active artificial progestinic agent in threatened abortions in the first trimester of pregnancy. Clinical study].
|
pubmed:publicationType |
Journal Article
|